Eloxx Pharmaceuticals, Inc. (ELOX) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $6.36M | — |
| 2023 | $0 | — |
| 2014 | $182.2K | +2230.6% |
| 2013 | $7.8K | — |
| 2010 | $140.0K | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $6.36M | — |
| 2023 | $0 | — |
| 2014 | $182.2K | +2230.6% |
| 2013 | $7.8K | — |
| 2010 | $140.0K | — |